|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wolf E, Rich NE, Marrero JA, Parikh ND and
Singal AG: Use of hepatocellular carcinoma surveillance in patients
with cirrhosis: A systematic review and meta-analysis. Hepatology.
73:713–725. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chan LK, Tsui YM, Ho DW and Ng IO:
Cellular heterogeneity and plasticity in liver cancer. Semin Cancer
Biol. 82:134–149. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Caruso S, O'Brien DR, Cleary SP, Roberts
LR and Zucman-Rossi J: Genetics of hepatocellular carcinoma:
Approaches to explore molecular diversity. Hepatology. 73 (Suppl
1):S14–S26. 2021. View Article : Google Scholar
|
|
5
|
Sun T, Yu Y, Wu X, Acevedo A, Luo JD, Wang
J, Schneider WM, Hurwitz B, Rosenberg BR, Chung H and Rice CM:
Decoupling expression and editing preferences of ADAR1 p150 and
p110 isoforms. Proc Natl Acad Sci USA. 118:e20217571182021.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xu R, Rai A, Chen M, Suwakulsiri W,
Greening DW and Simpson RJ: Extracellular vesicles in
cancer-implications for future improvements in cancer care. Nat Rev
Clin Oncol. 15:617–638. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nishikura K: A-to-I editing of coding and
non-coding RNAs by ADARs. Nat Rev Mol Cell Biol. 17:83–96. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Paz-Yaacov N, Bazak L, Buchumenski I,
Porath HT, Danan-Gotthold M, Knisbacher BA, Eisenberg E and Levanon
EY: Elevated RNA editing activity is a major contributor to
transcriptomic diversity in tumors. Cell Rep. 13:267–276. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Han L, Diao L, Yu S, Xu X, Li J, Zhang R,
Yang Y, Werner HMJ, Eterovic AK, Yuan Y, et al: The genomic
landscape and clinical relevance of A-to-I RNA editing in human
cancers. Cancer Cell. 28:515–528. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen L, Li Y, Lin CH, Chan TH, Chow RK,
Song Y, Liu M, Yuan YF, Fu L, Kong KL, et al: Recoding RNA editing
of AZIN1 predisposes to hepatocellular carcinoma. Nat Med.
19:209–216. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fritzell K, Xu LD, Lagergren J and Öhman
M: ADARs and editing: The role of A-to-I RNA modification in cancer
progression. Semin Cell Dev Biol. 79:123–130. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Okugawa Y, Toiyama Y, Shigeyasu K,
Yamamoto A, Shigemori T, Yin C, Ichikawa T, Yasuda H, Fujikawa H,
Yoshiyama S, et al: Enhanced AZIN1 RNA editing and overexpression
of its regulatory enzyme ADAR1 are important prognostic biomarkers
in gastric cancer. J Transl Med. 16:3662018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shigeyasu K, Okugawa Y, Toden S, Miyoshi
J, Toiyama Y, Nagasaka T, Takahashi N, Kusunoki M, Takayama T,
Yamada Y, et al: AZIN1 RNA editing confers cancer stemness and
enhances oncogenic potential in colorectal cancer. JCI Insight.
3:e999762018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qin YR, Qiao JJ, Chan TH, Zhu YH, Li FF,
Liu H, Fei J, Li Y, Guan XY and Chen L: Adenosine-to-inosine RNA
editing mediated by ADARs in esophageal squamous cell carcinoma.
Cancer Res. 74:840–851. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Peng X, Xu X, Wang Y, Hawke DH, Yu S, Han
L, Zhou Z, Mojumdar K, Jeong KJ, Labrie M, et al: A-to-I RNA
editing contributes to proteomic diversity in cancer. Cancer Cell.
33:817–828.e7. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kalluri R and LeBleu VS: The biology,
function, and biomecial applications of exosomes. Science.
367:eaau69772020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sekiba K, Otsuka M, Ohno M, Yamagami M,
Kishikawa T, Suzuki T, Ishibashi R, Seimiya T, Tanaka E and Koike
K: Inhibition of HBV transcription from cccDNA with nitazoxanide by
targeting the HBx-DDB1 interaction. Cell Mol Gastroenterol Hepatol.
7:297–312. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Oishi M, Munesue S, Harashima A, Nakada M,
Yamamoto Y and Hayashi Y: Aquaporin 1 elicits cell motility and
coordinates vascular bed formation by downregulating thrombospondin
type-1 domain-containing 7A in glioblastoma. Cancer Med.
9:3904–3917. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kishikawa T, Otsuka M, Yoshikawa T, Ohno
M, Yamamoto K, Yamamoto N, Kotani A and Koike K: Quantitation of
circulating satellite RNAs in pancreatic cancer patients. JCI
Insight. 1:e866462016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Uhlen M, Zhang C, Lee S, Sjöstedt E,
Fagerberg L, Bidkhori G, Benfeitas R, Arif M, Liu Z, Edfors F, et
al: A pathology atlas of the human cancer transcriptome. Science.
357:eaan2502017. View Article : Google Scholar
|
|
22
|
Shimizu T, Aoki T, Mori S, Iso Y, Kato M,
Ishizuka M and Kubota K: Tumor DNA-dependent protein kinase
catalytic subunit expression is associated with hepatitis B surface
antigen status and tumor progression in patients with
hepatocellular carcinoma. Sci Rep. 8:150192018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chan TH, Lin CH, Qi L, Fei J, Li Y, Yong
KJ, Liu M, Song Y, Chow RK, Ng VH, et al: A disrupted RNA editing
balance mediated by ADARs (Adenosine DeAminases that act on RNA) in
human hepatocellular carcinoma. Gut. 63:832–843. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Perez-Hernandez D, Gutiérrez-Vázquez C,
Jorge I, López-Martín S, Ursa A, Sánchez-Madrid F, Vázquez J and
Yáñez-Mó M: The intracellular interactome of tetraspanin-enriched
microdomains reveals their function as sorting machineries toward
exosomes. J Biol Chem. 288:11649–11661. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shi L, Yan P, Liang Y, Sun Y, Shen J, Zhou
S, Lin H, Liang X and Cai X: Circular RNA expression is suppressed
by androgen receptor (AR)-regulated adenosine deaminase that acts
on RNA (ADAR1) in human hepatocellular carcinoma. Cell Death Dis.
8:e31712017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gao X, Zhang Z, Mashimo T, Shen B, Nyagilo
J, Wang H, Wang Y, Liu Z, Mulgaonkar A, Hu XL, et al: Gliomas
interact with non-glioma brain cells via extracellular vesicles.
Cell Rep. 30:2489–2500.e5. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang H, Chen S, Wei J, Song G and Zhao Y:
A-to-I RNA editing in cancer: From evaluating the editing level to
exploring the editing effects. Front Oncol. 10:6321872020.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tan MH, Li Q, Shanmugam R, Piskol R,
Kohler J, Young AN, Liu KI, Zhang R, Ramaswami G, Ariyoshi K, et
al: Dynamic landscape and regulation of RNA editing in mammals.
Nature. 550:249–254. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Samuel CE: Adenosine deaminase acting on
RNA (ADAR1), a suppressor of double-stranded RNA-triggered innate
immune responses. J Biol Chem. 294:1710–1720. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kosaka N, Yoshioka Y, Fujita Y and Ochiya
T: Versatile roles of extracellular vesicles in cancer. J Clin
Invest. 126:1163–1172. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mathivanan S, Fahner CJ, Reid GE and
Simpson RJ: ExoCarta 2012: Database of exosomal proteins, RNA and
lipids. Nucleic Acids Res. 40:(Database Issue). D1241–D1244. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yamagami M, Otsuka M, Kishikawa T, Sekiba
K, Seimiya T, Tanaka E, Suzuki T, Ishibashi R, Ohno M and Koike K:
ISGF3 with reduced phosphorylation is associated with constitutive
expression of interferon-induced genes in aging cells. NPJ Aging
Mech Dis. 4:112018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Maeso-Díaz R, Ortega-Ribera M,
Fernández-Iglesias A, Hide D, Muñoz L, Hessheimer AJ, Vila S,
Francés R, Fondevila C, Albillos A, et al: Effects of aging on
liver microcirculatory function and sinusoidal phenotype. Aging
Cell. 17:e128292018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yoshimoto S, Loo TM, Atarashi K, Kanda H,
Sato S, Oyadomari S, Iwakura Y, Oshima K, Morita H, Hattori M, et
al: Obesity-induced gut microbial metabolite promotes liver cancer
through senescence secretome. Nature. 499:97–101. 2013. View Article : Google Scholar : PubMed/NCBI
|
